Details for 2012801442
Up to date per 03.04.2026
Actions
Details for 2012801442
Granted/Registered
European Patent
03.09.2014 A
19.04.2017 B1
28.10.2011
US
201161553094 P
06.03.2012
US
201261607487 P
06.03.2012
US
201261607503 P
A61K 31/495 20060101AFI20160704BHEP
Owner
Shire Human Genetic Therapies, Inc.300 Shire Way Lexington MA 02421US
Representative
Representative
HÄUPL & ELLMEYER KG PATENTANWALTSKANZLEIMariahilfer Straße 501070 WienAT
Inventor
GEDULIN, Bronislava14174 Half Moon Bay Dr. Del Mar, CA 92014US
GREY, MichaelP.O. Box 675614 Rancho Santa Fe, CA 92067US
O'DONNELL, Niall1046 Dewitt Ave. Encinitas, CA 92024US
Information about Fees